Trial Profile
Tolerability, pharmacokinetics and Pharmacodynamics of Midazolam Nasal Spray (USL261) in Healthy Geriatric and Non-Geriatric Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Feb 2018
Price :
$35
*
At a glance
- Drugs Midazolam (Primary)
- Indications Seizures
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 04 Mar 2016 New trial record